Serum total and HDL cholesterol and risk of prostate cancer
about
Obesity and cancer: mechanistic insights from transdisciplinary studiesMetabolic profiling of cholesterol and sex steroid hormones to monitor urological diseasesHypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomyA new use for an old index: preoperative high-density lipoprotein predicts recurrence in patients with hepatocellular carcinoma after curative resections.Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow upRole of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH databaseTotal serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can)The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate CancerMetabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS studyClinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy.Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study.Body mass index, serum total cholesterol, and risk of gastric high-grade dysplasia: A case-control study among Chinese adults.Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer.LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis.High-density lipoprotein and prostate cancer: an overview.The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review.CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer.Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.MicroRNA: a connecting road between apoptosis and cholesterol metabolism.Is PSA related to serum cholesterol and does the relationship differ between black and white men?Is cholesterol a mediator of cold-induced cancer?Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness.The role of statins in patients after heart transplantation.Cholesterol and prostate cancer.BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people.Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study.
P2860
Q26786829-B92A80C5-0C94-487F-BC84-725DF812A3C3Q28079470-4BE5C05F-5370-4A7B-8CC1-6296647028D9Q28544975-1B8492C5-0EC5-4CB9-A75A-B187AEEC9887Q33837659-A6B8626C-148E-4979-AC26-AF19BCC61994Q34133206-847B6A7B-069A-47B7-B2C0-F95B2097EE41Q34158413-2A95C97E-8935-4E8E-A259-BC8AF2316BC9Q34289164-F6A52DCD-21DD-4F06-8946-8FB1C2D6A4A3Q34458822-C94357AD-9692-47BC-8822-0B0831252224Q34571058-FC1D1F9E-B15F-41D2-86E2-96CB2FADCB6EQ35882782-FAEC85AB-9684-4272-A0D1-4B960F8B715CQ35935362-99F0FA5A-5F6F-4393-8DAF-05B959BEC59AQ36151318-4CD71943-7508-400A-9A9B-6D7E7F2A5170Q36293122-47EAC70E-1FC3-4510-AD80-E89842A18090Q36584255-D56F2E14-B12F-420B-818A-6BBDCF929EA5Q37205399-67996DE1-0717-4A38-ADF9-FD6A50ED857FQ37226386-DBB48CCE-3BE9-4BC0-A320-18BE3427F515Q37577156-8FDD0E94-ECC5-4559-A581-F7FAC41B7DFFQ38077536-FF0E0689-7198-4C70-B17A-A66D5DB88B52Q38088550-4FB3B5FE-99A7-449B-B8BD-D11ECB91409BQ38132333-A65454F8-8101-4415-BA12-C715FED568F1Q38151145-13521650-CA11-4D5A-84E8-E27F8E5161C9Q38719045-3352F3C1-5461-45D8-988D-2897283556A3Q38728309-F9E90284-398E-437D-8C36-BF98DD6910D0Q38815056-2C99BB02-C3B0-4E75-B4B9-17AC71860016Q38968138-09D9AF02-0A0F-4166-8F04-E5B049FFC15AQ40075493-17B80838-1ACF-4E7E-A2A7-514AAB79170BQ41470928-141431D4-5E3C-4450-8DC5-3E1C165EDAAEQ41893277-44400942-20C4-4C1A-98E1-4C5A21C7293BQ42079833-DBF157A3-07F7-44C2-866B-3916C0C85434Q42371605-F9385E30-D484-4480-A80D-48F601B634A1Q47241309-CEA238CB-03B1-42BB-9753-102DB4A6EDD1
P2860
Serum total and HDL cholesterol and risk of prostate cancer
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Serum total and HDL cholesterol and risk of prostate cancer
@ast
Serum total and HDL cholesterol and risk of prostate cancer
@en
type
label
Serum total and HDL cholesterol and risk of prostate cancer
@ast
Serum total and HDL cholesterol and risk of prostate cancer
@en
prefLabel
Serum total and HDL cholesterol and risk of prostate cancer
@ast
Serum total and HDL cholesterol and risk of prostate cancer
@en
P2860
P50
P1476
Serum total and HDL cholesterol and risk of prostate cancer
@en
P2093
Stephanie J Weinstein
P2860
P2888
P304
P356
10.1007/S10552-011-9831-7
P577
2011-09-14T00:00:00Z